Compounds > y 27632
Page last updated: 2024-09-03

y 27632 and Cholestasis, Intrahepatic

y 27632 has been researched along with Cholestasis, Intrahepatic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Hagihara, Y; Sonoi, R1
Burban, A; Burbank, MG; Guguen-Guillouzo, C; Guillouzo, A; Sharanek, A; Weaver, RJ1
Dold, S; Jeppsson, B; Laschke, MW; Menger, MD; Schilling, MK; Thorlacius, H1

Other Studies

3 other study(ies) available for y 27632 and Cholestasis, Intrahepatic

ArticleYear
Switching of cell fate through the regulation of cell growth during drug-induced intrahepatic cholestasis.
    Journal of bioscience and bioengineering, 2020, Volume: 130, Issue:6

    Topics: Amides; Bosentan; Cell Line; Cell Proliferation; Cholestasis, Intrahepatic; Humans; Pyridines

2020
Early Alterations of Bile Canaliculi Dynamics and the Rho Kinase/Myosin Light Chain Kinase Pathway Are Characteristics of Drug-Induced Intrahepatic Cholestasis.
    Drug metabolism and disposition: the biological fate of chemicals, 2016, Volume: 44, Issue:11

    Topics: Amides; Bile Acids and Salts; Bile Canaliculi; Biological Transport; Carrier Proteins; Cell Line; Cholestasis, Intrahepatic; Humans; Liver; Membrane Glycoproteins; Multidrug Resistance-Associated Proteins; Myosin-Light-Chain Kinase; Pyridines; rho-Associated Kinases; Signal Transduction; Taurocholic Acid

2016
Rho-kinase inhibitor attenuates cholestasis-induced CXC chemokine formation, leukocyte recruitment, and hepatocellular damage in the liver.
    The Journal of surgical research, 2010, Volume: 159, Issue:2

    Topics: Alanine Transaminase; Amides; Animals; Antihypertensive Agents; Aspartate Aminotransferases; Chemokines, CXC; Cholestasis; Cholestasis, Intrahepatic; Enzyme-Linked Immunosorbent Assay; Liver; Male; Mice; Mice, Inbred C57BL; Pyridines; rho-Associated Kinases

2010